Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 15 (RN7SKP15) is classified as a processed pseudogene of the 7SK small nuclear RNA gene. Unlike the functional RN7SK, which regulates RNA polymerase II transcriptional elongation and splicing via interaction with the positive transcription elongation factor b (P-TEFb)[1][2], RN7SKP15 does not produce a functional RNA or protein product and has not been implicated in any known biological roles, diseases, or as a therapeutic target. No information suggests that RN7SKP15 is expressed, functional, or druggable. The functional RN7SK RNA (not RN7SKP15, but the parent gene) is known to orchestrate control of transcriptional pausing and regulate the activity of RNA polymerase II, thereby influencing cellular differentiation, cell cycle progression, and immune cell polarization[1][2]. However, RN7SKP15 is only a pseudogene, without evidence for transcriptional activity or biological relevance. Most gene and functional references found in the literature pertain specifically to RN7SK, not its pseudogenes. RN7SKP15 is not a canonical receptor, enzyme, transporter, or drug target. It is a pseudogene of RN7SK, and no scientific evidence supports its use as a therapeutic or diagnostic target. If your intention is to investigate the functional 7SK small nuclear RNA, refer instead to RN7SK or its roles in Pol II transcriptional regulation[1][2]. If you want information about the pseudogene RN7SKP15, there is no evidence of function, disease role, or therapeutic relevance.
None (this entity does not encode a functional product)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 15 (RN7SKP15).